MicroActive® Resveratrol


Resveratrol is an antioxidant polyphenol with great promise for supporting healthy metabolism, normal insulin sensitivity and optimal blood flow — all of which may have cardiovascular, brain and anti-aging benefits.*

However, resveratrol, while reasonably well-absorbed, has a very short half-life. Because it does not stay in the bloodstream very long, its benefits can be difficult to reap. MicroActive Resveratrol was developed to address this issue through a micronized, sustained-release technology that allows for better absorption and retention.

A pilot human study comparing MicroActive Resveratrol to other resveratrol formulations showed it:

  • Has superior bioavailability: 2.5x greater than regular resveratrol[1]
  • Achieves higher serum levels of resveratrol over a longer period of time[2]
  • Delivers sustained release over 12 hours

 

STATUS

FUNCTIONS

Healthy Aging


      MECHANISM OF ACTION

      MicroActive Resveratrol is micronized, meaning the particles have been reduced to a small particle size (10 microns) allowing for greater transport through veins and capillaries. In addition, the special mix of polymers in MicroActive Resveratrol slows the rate at which the resveratrol is released, so it stays in the bloodstream longer.

      SAFETY

      Resveratrol is found in many plant foods such as grapes, red wine and peanuts. Several human clinical studies have confirmed its safety.[3],[4],[5],[6] Large doses can cause stomach upset, but MicroActive technology eliminates the need for excessive consumption by helping deliver smaller, more bioavailable doses to the body.

      [1] MicroActive® Resveratrol Powder (30%) In Vitro and In Vivo Studies MicroActive® Resveratrol Dissolution Test. Unpublished paper. June 2011.

      [2] MicroActive® Resveratrol Powder (30%) In Vitro and In Vivo Studies MicroActive® Resveratrol Dissolution Test. Unpublished paper. June 2011.

      [3] Almeida L, et al. Mol Nutr Food Res. 2009 May; 53 Suppl 1:S7-15.

      [4] Howells LM, et al. Cancer Prev Res. 2011 Sep; 4(9):1419-25.

      [5] Brown VA, et al. Cancer Res. 2010 Nov 15; 70(22):9003-11.

      [6] Edwards JA, et al Ann NY Acad Sci. 2011 Jan;1215:131-7.